Literature DB >> 14982798

Quantitative analysis of a parasitic antiviral strategy.

Hwijin Kim1, John Yin.   

Abstract

We extended a computer simulation of viral intracellular growth to study a parasitic antiviral strategy that diverts the viral replicase toward parasite growth. This strategy inhibited virus growth over a wide range of conditions, while minimizing host cell perturbations. Such parasitic strategies may inhibit the development of drug-resistant virus strains.

Mesh：

Substances：

Year:  2004        PMID： 14982798      PMCID： PMC353149          DOI： 10.1128/AAC.48.3.1017-1020.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  18 in total

Review 1.  Strategies in the design of antiviral drugs.

Authors:  Erik De Clercq
Journal:  Nat Rev Drug Discov       Date:  2002-01       Impact factor: 84.694

2.  Kinetic and thermodynamic characterization of the interaction between Q beta-replicase and template RNA molecules.

Authors:  M Werner
Journal:  Biochemistry       Date:  1991-06-18       Impact factor: 3.162

Review 3.  The hypercycle. Coupling of RNA and protein biosynthesis in the infection cycle of an RNA bacteriophage.

Authors:  M Eigen; C K Biebricher; M Gebinoga; W C Gardiner
Journal:  Biochemistry       Date:  1991-11-19       Impact factor: 3.162

4.  Kinetics of RNA replication: competition and selection among self-replicating RNA species.

Authors:  C K Biebricher; M Eigen; W C Gardiner
Journal:  Biochemistry       Date:  1985-11-05       Impact factor: 3.162

5.  Viral escape from antisense RNA.

Authors:  J J Bull; A Jacobson; M R Badgett; I J Molineux
Journal:  Mol Microbiol       Date:  1998-05       Impact factor: 3.501

6.  Replication and evolution of short-chained RNA species replicated by Q beta replicase.

Authors:  C K Biebricher
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1987

Review 7.  The making of a phage.

Authors:  C Weissmann
Journal:  FEBS Lett       Date:  1974-03-23       Impact factor: 4.124

8.  A novel immune system against bacteriophage infection using complementary RNA (micRNA).

Authors:  J Coleman; A Hirashima; Y Inokuchi; P J Green; M Inouye
Journal:  Nature       Date:  1985 Jun 13-19       Impact factor: 49.962

Review 9.  Virus population dynamics, fitness variations and the control of viral disease: an update.

Authors:  E Domingo; A Mas; E Yuste; N Pariente; S Sierra; M Gutiérrez-Riva; L Menéndez-Arias
Journal:  Prog Drug Res       Date:  2001

10.  Pathogen-derived resistance to viral infection using a negative regulatory molecule.

Authors:  R Grumet; J C Sanford; S A Johnston
Journal:  Virology       Date:  1987-12       Impact factor: 3.616
View more
  8 in total

Review 1.  Kinetic Modeling of Virus Growth in Cells.

Authors:  John Yin; Jacob Redovich
Journal:  Microbiol Mol Biol Rev       Date:  2018-03-28       Impact factor: 11.056

2.  Robust growth of human immunodeficiency virus type 1 (HIV-1).

Authors:  Hwijin Kim; John Yin
Journal:  Biophys J       Date:  2005-07-29       Impact factor: 4.033

3.  Multiple-hit inhibition of infection by defective interfering particles.

Authors:  Kristen A Stauffer Thompson; Grzegorz A Rempala; John Yin
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

4.  Implications of decoupling the intracellular and extracellular levels in multi-level models of virus growth.

Authors:  Eric L Haseltine; John Yin; James B Rawlings
Journal:  Biotechnol Bioeng       Date:  2008-11-01       Impact factor: 4.530

5.  Population dynamics of an RNA virus and its defective interfering particles in passage cultures.

Authors:  Kristen A Stauffer Thompson; John Yin
Journal:  Virol J       Date:  2010-09-29       Impact factor: 4.099

6.  Inhibition of infection spread by co-transmitted defective interfering particles.

Authors:  Ashley Baltes; Fulya Akpinar; Bahar Inankur; John Yin
Journal:  PLoS One       Date:  2017-09-15       Impact factor: 3.240

7.  Multiscale modeling of influenza A virus infection supports the development of direct-acting antivirals.

Authors:  Frank S Heldt; Timo Frensing; Antje Pflugmacher; Robin Gröpler; Britta Peschel; Udo Reichl
Journal:  PLoS Comput Biol       Date:  2013-11-21       Impact factor: 4.475

Review 8.  Exploiting Genetic Interference for Antiviral Therapy.

Authors:  Elizabeth J Tanner; Karla A Kirkegaard; Leor S Weinberger
Journal:  PLoS Genet       Date:  2016-05-05       Impact factor: 5.917
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.